• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移至眼眶的支气管肺非典型类癌肿瘤。

Bronchopulmonary atypical carcinoid tumour metastatic to the orbit.

作者信息

Aburn N S, Whitehead K, Sullivan T J

机构信息

Department of Surgery, Royal Brisbane Hospital, Herston, Queensland.

出版信息

Aust N Z J Ophthalmol. 1995 Aug;23(3):241-4. doi: 10.1111/j.1442-9071.1995.tb00166.x.

DOI:10.1111/j.1442-9071.1995.tb00166.x
PMID:8534453
Abstract

BACKGROUND

Bronchopulmonary carcinoid tumours metastatic to the orbit are rare. A case is presented demonstrating presentation, histopathology and treatment.

METHODS

A 64-year-old man with a history of bronchopulmonary atypical carcinoid presented with an orbital mass. The nature of this metastasis was confirmed with histology and it was surgically excised and, in addition, local radiotherapy and chemotherapy were administered.

RESULTS

There was a good response to the treatment for the orbital mass but other metastases developed, causing death.

CONCLUSIONS

In this case of atypical carcinoid, orbital metastasis was the first sign of disease progression. Histological confirmation of the diagnosis was important in this case to allow planning of oncological therapy and for appropriate patient counselling. A good local response was obtained with a combination of surgical excision, local radiotherapy and chemotherapy. The systemic prognosis remains poor in cases of metastatic bronchopulmonary atypical carcinoid tumour, in contrast to typical carcinoid.

摘要

背景

转移至眼眶的支气管肺类癌肿瘤罕见。本文报告一例,展示其临床表现、组织病理学及治疗情况。

方法

一名有支气管肺非典型类癌病史的64岁男性出现眼眶肿物。通过组织学确诊了该转移灶,并进行了手术切除,此外还给予了局部放疗和化疗。

结果

眼眶肿物的治疗效果良好,但出现了其他转移灶,导致患者死亡。

结论

在该非典型类癌病例中,眼眶转移是疾病进展的首个迹象。在本病例中,组织学确诊对制定肿瘤治疗方案及为患者提供恰当咨询很重要。手术切除、局部放疗和化疗联合应用取得了良好的局部治疗效果。与典型类癌不同,转移性支气管肺非典型类癌肿瘤的全身预后仍然很差。

相似文献

1
Bronchopulmonary atypical carcinoid tumour metastatic to the orbit.转移至眼眶的支气管肺非典型类癌肿瘤。
Aust N Z J Ophthalmol. 1995 Aug;23(3):241-4. doi: 10.1111/j.1442-9071.1995.tb00166.x.
2
Orbital carcinoid metastases.眼眶类癌转移
Ophthalmology. 2006 Mar;113(3):466-72. doi: 10.1016/j.ophtha.2005.10.051. Epub 2006 Feb 3.
3
Clinical features and treatment of seven patients with carcinoid tumor metastatic to the eye and orbit.7例类癌转移至眼和眼眶患者的临床特征及治疗
Am J Ophthalmol. 1995 Feb;119(2):211-8. doi: 10.1016/s0002-9394(14)73875-9.
4
Metastatic carcinoid tumor in the orbit.
Kurume Med J. 2003;50(3-4):165-7. doi: 10.2739/kurumemedj.50.165.
5
The role of endoscopic sinus surgery in the diagnosis and treatment of metastatic orbital carcinoid tumors.内镜鼻窦手术在转移性眼眶类癌肿瘤诊断和治疗中的作用。
Ear Nose Throat J. 2007 Mar;86(3):157-61.
6
Metastatic carcinoid tumor to the orbit and brain.
Neurosurgery. 1992 Nov;31(5):949-52; discussion 952. doi: 10.1227/00006123-199211000-00020.
7
Typical bronchopulmonary carcinoid tumors: a ramifying bronchial presentation with metastatic behavior.
Ann Thorac Surg. 2006 Dec;82(6):2265-6. doi: 10.1016/j.athoracsur.2006.05.012.
8
Gastrointestinal carcinoid tumor metastatic to the orbit.
South Med J. 1989 Dec;82(12):1549-52. doi: 10.1097/00007611-198912000-00022.
9
Carcinoid tumour metastatic to the orbit with infiltration to the extraocular orbital muscle.类癌转移至眼眶并浸润至眶外眼肌。
APMIS. 2005 Feb;113(2):135-9. doi: 10.1111/j.1600-0463.2005.apm1130207.x.
10
Secondary SUNCT due to intraorbital, metastatic bronchial carcinoid.继发于眶内转移性支气管类癌的SUNCT(短时限单侧神经痛性头痛发作伴结膜充血及流泪综合征)
Cephalalgia. 2005 Aug;25(8):633-5. doi: 10.1111/j.1468-2982.2005.00917.x.

引用本文的文献

1
Diagnostic and Therapeutic Management of Primary Orbital Neuroendocrine Tumors (NETs): Systematic Literature Review and Clinical Case Presentation.原发性眼眶神经内分泌肿瘤(NETs)的诊断与治疗管理:系统文献综述及临床病例报告
Biomedicines. 2024 Feb 6;12(2):379. doi: 10.3390/biomedicines12020379.